10-01 :: January 2010
nanotimes
17
Companies
Facts
carbon anodes, offering an increase in cell capacity flexible, thus allowing the material to be rolled up,
of roughly 40%. wrapped, or easily cut with a scalpel.

http://www.amprius.com

http://www.bacterin.com

http://www.technologyreview.com/energy/23893/
A
MRI (NASDAQ: AMRI) will issue fourth quarter F
or 2009, Dow Chemical (NYSE: DOW) reported
full-year earnings of $0.32 per share, equiva-
and full year financial results before the opening lent to $0.63 per share excluding certain items and
of the market on Monday, February 8, 2010. discontinued operations. Reported earnings for 2008

http://www.amriglobal.com were $0.62 per share, or $1.79 per share exclu-
ding certain items and discontinued operations. Net
B
acterin International Inc. receives a $1.4 million income from continuing operations for the year was
investment. Bacterin International, designs, tests $566 million. This compares with net income from
and licenses bioactive coatings for medical applica- continuing operations in 2008 of $626 million.
tions. Bacterin’s Elutia™ family of silicone surgical
wound drains have been designed and developed to Dow reported full-year sales of $44.9 billion, down
utilize Bacterin‘s technology. The drains have a hy- 22% from reported sales in 2008. The company
drogel coating that contains the antimicrobial agent reported sequential sales improvements throughout
silver sulfadiazine. This coating has been shown to the year, but these gains were not enough to offset
reduce microbial contamination on the surface of the an overall sales decline of 30% versus 2008 on a
wound drain by greater than 99.99% over a 7 day pro forma basis. Despite one of the worst economic
period as tested under USP <51> conditions against environments in decades, cash provided by operating
the following microorganisms: S. aureus, P. aerugino- activities was $2.1 billion in 2009, and the Company
sa, E. coli, and C. albicans ended the year with a cash balance of $2.8 billion.
OsteoSponge
®
and OsteoWrap™ are two novel DOW ELECTRICAL MATERIALS introduced recently
Bacterin products that are currently distributed its new line of metallization and imaging products for
throughout the U.S. and internationally. Oste- printed circuit boards (PCB). These advanced materi-
oSponge
®
is a dynamic DBM allograft that is mal- als provide high-performance, cost effective solutions
leable (spongelike), yet maintains osteoinductive with improved environmental profiles for the PCB
and osteoconductive properties. OsteoSponge™ is industry:
a unique graft material that revolutionizes the hand-
ling properties of bone through a patent pending • PCB Electrolytic Plating – MICROFILL™ EVF Via Fill
process. Its porous structure provides an excellent provides greatly enhanced via filling at exceptionally
matrix for vascular growth and new bone formation. low surface thicknesses and is capable of simultane-
It is 100% bone, has sponge-like properties, and is an ous through-hole plating. It is suitable for both HDI
ideal alternative to gels, putties, and ill fitting grafts. and IC (Integrated Circuit) Substrate applications.
OsteoWrap™ is a thin sheath of cortical bone that is
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53